Shattuck Labs Inc. Company Profile
NASDAQ: STTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Shattuck Labs at a glance
Shattuck Labs Inc. (NASDAQ: STTK) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Austin, TX. Shattuck Labs is led by Dr. Taylor H. Schreiber M.D., Ph.D. and employs about 40 people. The company's shares have traded publicly since 2020.
At a market capitalization of $463.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001680367, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Shattuck Labs do?
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- Shattuck Labs Inc.
- Ticker
- NASDAQ: STTK
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Taylor H. Schreiber M.D., Ph.D.
- Employees
- 40
- Headquarters
- 500 West 5th Street, Austin, TX, United States
- Phone
- 512 900 4690
- Website
- shattucklabs.com
- IPO year
- 2020
- Market cap
- $463.38M
- SEC CIK
- 0001680367
- Latest annual report
- 10-K · Mar 5, 2026
Companies similar to Shattuck Labs
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BLSMBlossomHill Therapeutics Inc. | 14.51 | +0.69% | $461.20M | vs STTK |
| RZLTRezolute Inc. | 3.92 | -6.67% | $465.58M | vs STTK |
| GYREGyre Therapeutics Inc. | 4.21 | -6.86% | $460.79M | vs STTK |
| MNPRMonopar Therapeutics Inc. | 69.00 | -1.84% | $467.60M | vs STTK |
| NGNENeurogene Inc. | 22.15 | -3.40% | $458.53M | vs STTK |
| EVOEvotec SE ADR | 1.32 | -8.97% | $469.11M | vs STTK |
| ASMBAssembly Biosciences Inc. | 22.19 | -1.38% | $454.39M | vs STTK |
| KMDAKamada Ltd. | 7.74 | -1.15% | $446.85M | vs STTK |